Ab Source Biologics Private Limited, a active private limited company, was established on 05 November 2014 in Pune, Maharashtra, India. Engaging in dairy products & milk processing within the manufacturing sector, it holds CIN: U74900PN2014PTC152998. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.56 Cr.
It upholds a compliant status. Employing 26 professional, Its leadership includes Mukesh Vishwanath Vinze (Director), Jagannath Yashwant Sonavane (Director). Past directors included Narendra Panditrao Patil, Bikash Ajit Aich. It holds ₹4.80 M open charges and ₹2.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D-1, Block Pl No. 18/1,Midc Chinchwad, Pune, Maharashtra, 411019.
U74900PN2014PTC152998
152998
05 November 2014
₹2.00 Cr
₹1.56 Cr
Roc Pune
Unlisted
Active
Explore comprehensive insights into Ab Source Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Vishwanath Vinze | Director | 05 Nov 2014 | Current |
| Jagannath Yashwant Sonavane | Director | 05 Nov 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 23 Dec 2022 | Past |
| Pramod Abcsdd | Director | 27 Jun 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ab Source Biologics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 197.38% increase. The company also saw a substantial improvement in profitability, with a 73.97% increase in profit. The company's net worth dipped by a decrease of 5.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Ab Source Biologics had a promoter holding of 40.00% and a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,801,939.00
₹24,980,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jul 2025 | Others | ₹2.06 M | Open |
| 20 Sep 2024 | Hdfc Bank Limited | ₹2.74 M | Open |
| 05 Sep 2016 | Others | ₹2.00 Cr | Satisfied |
| 09 Dec 2015 | Axis Bank Limited | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Ab Source Biologics has a workforce of 26 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ab Source Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ab Source Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 0.21 Cr with Charge ID 101124102 was registered on 08 Jul 2025. was recorded as a recent event.
The activity A charge registered on 05 Sep 2016 via Charge ID 100069119 with Others was fully satisfied on 11 Mar 2025. was completed.
Ab Source Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.27 Cr with Charge ID 101039925 was registered on 20 Sep 2024. was completed.
The activity Ab Source Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.
The activity A charge registered on 09 Dec 2015 via Charge ID 10610729 with Axis Bank Limited was fully satisfied on 26 Apr 2021. was completed.
The CIN of Ab Source Biologics Private Limited is U74900PN2014PTC152998.
Ab Source Biologics Private Limited is headquartered at D-1, Block Pl No. 18/1,Midc Chinchwad, Pune, Maharashtra, 411019.
Ab Source Biologics Private Limited was incorporated on 05 November 2014.
The current directors of Ab Source Biologics Private Limited are
The primary industry of Ab Source Biologics Private Limited is Manufacturing.
Ab Source Biologics Private Limited is unlisted.
The authorized capital of Ab Source Biologics Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.56 Cr.
The compliance status of Ab Source Biologics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX